Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Keyt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|January 4, 2021
WHO recommends corticosteroids for patients with severe or critical COVID-19Holly Keyt
Annals of Internal Medicine|August 4, 2025
In patients with bronchiectasis, daily brensocatib reduced annualized pulmonary exacerbation ratesHolly Keyt,
The Indian Journal of Medical Research|August 12, 2014
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancementsHolly Keyt, Paola Faverio, Marcos I Restrepo
Journal of Asthma and Allergy|August 27, 2015
Profile of lebrikizumab and its potential in the treatment of asthmaDiego Jose Maselli, Holly Keyt, Linda Rogers
Respiratory Care|June 14, 2015
Aerosolized AntibioticsMarcos I Restrepo, Holly Keyt, Luis F Reyes
International Journal of Molecular Sciences|May 17, 2017
Inhaled Antibiotic Therapy in Chronic Respiratory DiseasesDiego J Maselli, Holly Keyt, Marcos I Restrepo
Breathe (Sheffield, England)|February 18, 2017
Global impact of bronchiectasis and cystic fibrosisMargarida Redondo, Holly Keyt, Raja Dhar, et al.
International Journal of Clinical Practice|February 27, 2017
Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to knowDiego J Maselli, Bravein Amalakuhan, Holly Keyt, et al.
JCEM Case Reports|April 3, 2026
Semaglutide as a potential tool in pre-lung transplant weight loss optimizationRoshaneh Ali, Holly Keyt, Carolina Solis-Herrera, et al.
Transplantation Proceedings|December 4, 2024
Treatment Response of Donor Specific Antibodies and Forced Expiratory Volume in Lung Transplant Recipients With Antibody Mediated RejectionElisabeth Kincaide, Alicia Brenner, Reed Hall, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|January 4, 2021
WHO recommends corticosteroids for patients with severe or critical COVID-19Holly Keyt
Annals of Internal Medicine|August 4, 2025
In patients with bronchiectasis, daily brensocatib reduced annualized pulmonary exacerbation ratesHolly Keyt,
The Indian Journal of Medical Research|August 12, 2014
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancementsHolly Keyt, Paola Faverio, Marcos I Restrepo
Journal of Asthma and Allergy|August 27, 2015
Profile of lebrikizumab and its potential in the treatment of asthmaDiego Jose Maselli, Holly Keyt, Linda Rogers
Respiratory Care|June 14, 2015
Aerosolized AntibioticsMarcos I Restrepo, Holly Keyt, Luis F Reyes
International Journal of Molecular Sciences|May 17, 2017
Inhaled Antibiotic Therapy in Chronic Respiratory DiseasesDiego J Maselli, Holly Keyt, Marcos I Restrepo
Breathe (Sheffield, England)|February 18, 2017
Global impact of bronchiectasis and cystic fibrosisMargarida Redondo, Holly Keyt, Raja Dhar, et al.
International Journal of Clinical Practice|February 27, 2017
Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to knowDiego J Maselli, Bravein Amalakuhan, Holly Keyt, et al.
JCEM Case Reports|April 3, 2026
Semaglutide as a potential tool in pre-lung transplant weight loss optimizationRoshaneh Ali, Holly Keyt, Carolina Solis-Herrera, et al.
Transplantation Proceedings|December 4, 2024
Treatment Response of Donor Specific Antibodies and Forced Expiratory Volume in Lung Transplant Recipients With Antibody Mediated RejectionElisabeth Kincaide, Alicia Brenner, Reed Hall, et al.
Pageof 2